Hunter Smith - Dec 29, 2023 Form 4 Insider Report for RHYTHM PHARMACEUTICALS, INC. (RYTM)

Role
Chief Financial Officer
Signature
/s/ Hunter Smith
Stock symbol
RYTM
Transactions as of
Dec 29, 2023
Transactions value $
$72,240
Form type
4
Date filed
1/3/2024, 04:15 PM
Previous filing
Dec 7, 2023
Next filing
Feb 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RYTM Common Stock Options Exercise $72.2K +10.5K +17.1% $6.88 71.9K Dec 29, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RYTM Stock Option (Right to Buy) Options Exercise $0 -10.5K -9.45% $0.00 101K Dec 29, 2023 Common Stock 10.5K $6.88 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options is fully vested.